Results 81 to 90 of about 4,097,121 (312)
, 2023 Aim: Research and innovation (R&I) actors are fundamental in shortening the translational gap of personalized medicine in health systems. In the context of the ‘Integrating China in the International Consortium for Personalized Medicine’ project, we ...
Ricciardi, Walter +14 more
core +1 more source
Reprogramming tumor cells with LCOR mRNA nanotherapy to enhance immunotherapy
Molecular Oncology, EarlyView.LCOR (Ligand‐dependent corepressor) mRNA encapsulated in polymeric nanoparticles restores LCOR activity in tumor cells, constraining aggressive tumor cell states and increasing tumor immunogenicity. This reprogramming makes tumor cells more vulnerable to T‐cell attack and enhances their response to immune‐checkpoint immunotherapy.
Gabriel Serra‐Mir +9 more
wiley +1 more source
Personalized (laboratory) medicine: a bridge to the future.
, 2013 Personalized (laboratory) medicine: a bridge to the ...
PLEBANI, MARIO +3 more
core +1 more source
Attitudes of cancer patients toward ctDNA‐based liquid biopsy for follow‐up
Molecular Oncology, EarlyView.This mixed‐methods study explored cancer patients' experiences, knowledge, and preferences regarding ctDNA‐based liquid biopsy for follow‐up. Awareness of ctDNA was low and recall of previous liquid biopsy was imperfect, yet acceptance was high.
Siddharth Chhajlani +7 more
wiley +1 more source
Personalized medicine: moving from simple theory to daily practice.
, 2015 Personalized medicine: moving from simple theory to daily ...
Lippi G, PLEBANI, MARIO, LIPPI, Giuseppe
core +1 more source
Implementing personalized medicine with asymmetric information on prevalence rates [PDF]
, 2016 Although personalized medicine is becoming the new paradigm to manage some diseases, the economics of personalized medicine have only focused on assessing the efficiency of specific treatments, lacking a theoretical framework analyzing the interactions ...
Carmelo A. Juárez-Castelló +11 more
core +2 more sources
Personalized Medicine in Europe
Clinical and Translational Science, 2017 Personalised medicine is a promising new concept for dealing with challenges of health and health systems. With the launch of the International Consortium of Personalised Medicine, which brings together health research funders and policy making organisations, European countries aim to coordinate research and health policy to advance the implementation ...
Nimmesgern, E +2 more
openaire +2 more sources
Loss of AMBRA1 activates MAPK and angiogenesis signaling pathways in melanoma cells
FEBS Open Bio, EarlyView.Loss of AMBRA1 in melanoma cells activates multiple oncogenic pathways associated with tumor progression. Transcriptomic and protein network analyses revealed that AMBRA1 depletion enhances MAPK/ERK signaling, angiogenesis, TGF‐β/EMT signaling, and Wnt/axon guidance pathways.
Milad Ibrahim +4 more
wiley +1 more source
Priorities for Personalized Medicine
, 2008 Advances in genomics and molecular biology have opened new possibilities for the field of personalized medicine, promising improvements in patient care, disease prevention, and possibly lower health care costs.
Subcommittee on Personalized Medicine +1 more
core
Personalized Medicine: Worth Its Cost? [PDF]
, 2015 Already stretched health care systems face a panoply of challenges, including a high and increasing number of patients with chronic conditions, expensive and rising costs of treatment, and stagnant economies.
Carrera, Percivil M.
core +1 more source